BPC 157 enhances the expression of genes associated with vascularization, such as Egr1 and Vegfr2, which are crucial for repairing and maintaining brain tissue
Brett Brechner, DO, with the most comprehensive peptide and GLP-1 program in Chicago
There are two exceptions that allow a provider to compound a GLP-1 drug: (1) if the drug is not commercially available, and (2) if the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. The identified change must be documented appropriately on the prescription or order
Back up ATP creation with micronutrient support such as magnesium, B vitamins, CoQ10, and iron as your labs dictate
The impact on rebates would also need to be considered